|
|
Volumn 25, Issue 33, 2007, Pages 5313-5318
|
|
American Society of Clinical Oncology endorsement of the Cancer Care Ontario practice Guideline on Nonhormonal Therapy for Men with Metastatic Hormone-Refractory (castration-resistant) Prostate Cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCITRIOL;
DOCETAXEL;
ESTRAMUSTINE;
FLUOROURACIL;
HYDROCORTISONE;
IXABEPILONE;
MITOXANTRONE;
PACLITAXEL;
PLACEBO;
PREDNISOLONE;
PREDNISONE;
VINBLASTINE;
CANCER GROWTH;
CANCER HORMONE THERAPY;
CANCER SURVIVAL;
CASTRATION;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DISEASE COURSE;
DRUG MEGADOSE;
HEALTH CARE POLICY;
HEALTH PROGRAM;
HORMONAL REGULATION;
HORMONE RESISTANCE;
HORMONE SENSITIVITY;
HUMAN;
LIFE EXPECTANCY;
MEDICAL SOCIETY;
META ANALYSIS;
METASTASIS;
MONOTHERAPY;
OUTCOME ASSESSMENT;
PATIENT CARE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
SYSTEMATIC REVIEW;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
HUMANS;
MALE;
NEOPLASM METASTASIS;
PRACTICE GUIDELINES AS TOPIC;
PROSTATIC NEOPLASMS;
|
|
EID: 36849038314
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2007.13.4536 Document Type: Review |
|
Times cited : (80)
|
|
References (7)
|
